Zimmer Biomet Holdings (ZBH) Research & Development (2009 - 2026)

Zimmer Biomet Holdings' Research & Development history runs 18 years deep, the most recent figure standing at $103.4 million for Q1 2026.

• On a quarterly basis, Research & Development fell 6.51% year-over-year to $103.4 million in Q1 2026; TTM through Mar 2026 was $451.3 million, a 2.54% increase from a year earlier, with the FY2025 full-year figure at $458.5 million, up 4.82% from the prior year.
• Research & Development slipped to $103.4 million in Q1 2026 per ZBH's latest filing, from $118.7 million in the prior quarter.
• Across five years, Research & Development topped out at $118.7 million in Q4 2025 and bottomed at $96.9 million in Q1 2022.
• The 5-year median for Research & Development is $110.4 million (2023), against an average of $109.6 million.
• Biggest YoY gain for Research & Development was 19.63% in 2022; the steepest drop was 39.76% in 2022.
• Year by year, Research & Development stood at $108.0 million in 2022, then gained by 4.91% to $113.3 million in 2023, then slipped by 4.24% to $108.5 million in 2024, then increased by 9.4% to $118.7 million in 2025, then slipped by 12.89% to $103.4 million in 2026.
• Per Business Quant, the three latest ZBH Research & Development figures stand at $103.4 million (Q1 2026), $118.7 million (Q4 2025), and $115.9 million (Q3 2025).